Modulation of the formalin-induced nociceptive response by diabetes: Possible involvement of protein kinase C

Brain Research

Volumn 803, Issue 1-2, 1998, Pages 198-203

  Ohsawa, Masahiro ^a   Kashiwazaki, Takako ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Calphostin C; Diabetes; Formalin induced nociception; Mouse; Phorbol 12,13 dibutyrate; Protein kinase C

Indexed keywords

CALPHOSTIN; FORMALDEHYDE; PHORBOL DIBUTYRATE; PROTEIN KINASE C; SOMATOSTATIN; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; DOSE RESPONSE; ENZYME ACTIVATION; MECHANICAL STIMULATION; MOUSE; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CELL; SPINAL CORD;

ANIMALS; BEHAVIOR, ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FORMALDEHYDE; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED ICR; PAIN MEASUREMENT; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C;

EID: 0032563718     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00615-5     Document Type: Article

References (38)

1. Allgren S.C., Levine J.D. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in streptozotocin-diabetic rat. J. Neurophysiol. 72:1994;684-692.
2. Barber L.A., Vasko M.R. Activation of protein kinase C augments peptide release from rat sensory neurons. J. Neurochem. 67:1996;72-80.
3. Burgess G.M., Mullaney I., McNeill M., Dunn P.M., Rang H.P. Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J. Neurosci. 9:1989;3314-3325.
4. Coderre T. Contribution of protein kinase C to central sensitization and persistent pain following tissue injury. Neurosci. Lett. 140:1992;181-184.
5. Coleman R.M., Smith W.L., Narumiya S. VII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:1994;206-229.
6. Craven P.A., De Rubertis F.R. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J. Clin. Invest. 83:1989;1667-1675.
7. Dray A., Bettany J., Forster P., Perkins M.N. Bradykinin-induced stimulation of afferent fibers is mediated through protein kinase C. Neurosci. Lett. 91:1988;301-307.
8. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
9. Gerber G., Kangrga I., Ryu P.D., Larew M., Randic M. Multiple effects of phorbol esters in the rat spinal dorsal horn. J. Neurosci. 9:1989;3606-3617.
10. Hayes R.L., Mao J., Price D.D., Germano A., d'Avella D., Fiori M., Mayer D.J. Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathy. Pain. 48:1992;391-396.
11. Hunskaar S., Fasmer O.B., Hole K. Formalin test in mice, a useful technique for evaluating mild analgesia. J. Neurosci. Meth. 14:1985;69-76.
12. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 30:1987;103-114.
13. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67:1980;313-316.
14. Inoguchi T., Battan R., Handler E., Sportsman J.R., Health W., King G.L. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA. 89:1992;11059-11063.
15. Kamei J., Hitosugi H., Kasuya Y. Formalin-induced nociceptive responses in diabetic mice. Neurosci. Lett. 149:1993;161-164.
16. 1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice. Eur. J. Pharmacol. 326:1997;31-36.
17. Kantner R.M., Goldenstein B.D., Kirby M.L. Regulatory mechanisms for substance P in the dorsal horn during a nociceptive stimulus: axoplasmic transport vs. electrical activity. Brain Res. 385:1986;282-290.
18. G.L. King, S. Johnson, G. Wu, Possible growth modulators involved in the pathogenesis of diabetic proliferate retinopathy, in: B. Westermark, C. Betscholtz, T. Hokfelt (Eds.), Growth Factors in Health and Diseases, Elsevier, Amsterdam, 1990, pp. 303-317.
19. Kuraishi Y., Hirota H., Sato Y., Hanashima N., Takagi H., Satoh M. Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ. Neuroscience. 30:1989;241-250.
20. Lou L.G., Pei G. Modulation of protein kinase C and c-AMP-dependent protein kinase C by delta-opioid. Biochem. Biophys. Res. Commun. 236:1997;626-629.
21. Mao J., Price D.D., Mayer D.J., Hayes R.L. Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury. Brain Res. 588:1992;144-149.
22. Murray C.W., Porreca F., Cowan A. Methodological refinements to the mouse paw formalin test. J. Pharmacol. Meth. 20:1988;175-186.
23. 3 determines G-protein specificity. Nature. 365:1993;166-170.
24. Narita M., Mizoguchi H., Kampine J.P., Tseng L.F. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br. J. Pharmacol. 118:1996;1829-1835.
25. Narita M., Ohsawa M., Mizoguchi H., Kamei J., Tseng L.F. Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ- but not ε-opioid receptor agonist in the mouse. Neuroscience. 76:1997;291-298.
26. Ohkubo T., Shibata M., Takahashi H., Inoki R. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord. J. Pharmacol. Exp. Ther. 252:1990;1261-1268.
27. Ohsawa M., Kamei J. Possible involvement of protein kinase C in the attenuation of DAMGO-induced antinociception in diabetic mice. Eur. J. Pharmacol. 339:1997;27-31.
28. Schepelmann K., Meßlinger K., Schmidt R.F. The effects of phorbol ester on slowly conducting afferents of the cat's knee joint. Exp. Brain Res. 92:1993;391-398.
29. Shiba T., Inoguchi T., Sportsman R., Health W., Bursell S.E., King G.L. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am. J. Physiol. 265:1993;E787-E793.
30. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 38:1989;347-352.
31. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of δ opioid agonists by naltrindole (NTI) and its benzofuran analog (NTB) in mice: evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;676-680.
32. Sofuoglu M., Portoghese P.S., Takemori A.E. Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for δ opioid receptor subtypes. Life Sci. 49:1991;PL153-156.
33. Sugimoto M., Kuraishi Y., Satoh M., Takagi H. Involvement of medullary opioid-peptidergic and spinal noradrenergic systems in the regulation of formalin-induced persistent pain. Neuropharmacology. 25:1986;481-485.
34. Tanaka A., Kashiwagi Y., Ogawa T., Abe N., Asahina T., Ikebuchi M., Takagi Y., Shigeta Y. Effect of verapamil on cardiac protein kinase C activity in diabetic rats. Eur. J. Pharmacol. 200:1991;353-356.
35. 5-enkephalin from rat spinal cord. Neuropharmacology. 22:1983;1147-1150.
36. Vaccarino F., Guidotti A., Costa E. Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc. Natl. Acad. Sci. USA. 84:1987;8707-8711.
37. Wolf B.A., Williamson J.R., Easom R.A., Chang K., Sherman W.R., Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J. Clin. Invest. 98:1991;31-38.
38. Yashpal K., Pitcher G.M., Parent A., Quirion R., Coderre T.J. Noxious thermal and chemical stimulation induce increase in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. J. Neurosci. 15:1995;3263-3272.